The drug is being developed for metastatic non-small cell lung cancer (NSCLC) in patients whose tumours have an […]
Updated Date: Fri, 08 May 2020 00:00:00 EDT
Updated Date: Fri, 08 May 2020 00:00:00 EDT
Updated Date: Fri, 08 May 2020 00:00:00 EDT
Updated Date: Fri, 08 May 2020 00:00:00 EDT
Updated Date: Fri, 08 May 2020 00:00:00 EDT
Bristol Myers Squibb finally breaks into first-line lung cancer with Opdivo-Yervoy nod chelfand Fri, 05/15/2020 – 16:11
After sneak peak at early data, Operation Warp Speed head Slaoui ‘confident’ in COVID-19 vaccine by year’s end […]
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with […]
